Related Experiment Video
Updated: May 17, 2026

Yeast Luminometric and Xenopus Oocyte Electrophysiological Examinations of the Molecular Mechanosensitivity of TRPV4
Published on: December 31, 2013
Human skeletal dysplasia caused by a constitutive activated transient receptor potential vanilloid 4 (TRPV4) cation
Sang Sun Kang1, Sung Hwa Shin, Chung-Kyoon Auh
1Department of Biology Education Chungbuk National University Cheongju 361-763, Korea. jin95324@cbu.ac.kr
Abstract:
The transient receptor potential vanilloid 4 (TRPV4) cation channel, a member of the TRP vanilloid subfamily, is expressed in a broad range of tissues where it participates in the generation of Ca²⁺ signals and/or depolarization of the membrane potential. Regulation of TRPV4 abundance at the cell surface is critical for osmo- and mechanotransduction. Defects in TRPV4 are the cause of several human diseases, including brachyolmia type 3 (MIM:113500) (also known as brachyrachia or spondylometaphyseal dysplasia Kozlowski type [MIM:118452]), and metatropic dysplasia (MIM:156530) (also called metatropic dwarfism or parastremmatic dwarfism [MIM:168400]). These bone dysplasia mutants are characterized by severe dwarfism, kyphoscoliosis, distortion and bowing of the extremities, and contractures of the large joints. These diseases are characterized by a combination of decreased bone density, bowing of the long bones, platyspondyly, and striking irregularities of endochondral ossification with areas of calcific stippling and streaking in radiolucent epiphyses, metaphyses, and apophyses. In this review, we discuss the potential effect of the mutation on the regulation of TRPV4 functions, which are related to human diseases through deviated function. In particular, we emphasize how the constitutive active TRPV4 mutant affects endochondral ossification with a reduced number of hypertrophic chondrocytes and the presence of cartilage islands within the zone of primary mineralization. In addition, we summarize current knowledge about the role of TRPV4 in the pathogenesis of several diseases.
Insights
Mutations in the transient receptor potential vanilloid 4 (TRPV4) channel cause bone diseases by altering its function. This review explores TRPV4
Area of Science:
- Molecular Biology
- Genetics
- Skeletal Dysplasias
Background:
- The transient receptor potential vanilloid 4 (TRPV4) cation channel is crucial for cellular signaling and membrane potential regulation.
- TRPV4 cell surface abundance is vital for osmo- and mechanotransduction.
- TRPV4 defects are linked to human skeletal dysplasias like brachyolmia type 3 and metatropic dysplasia.
Purpose of the Study:
- To review the impact of TRPV4 mutations on its function and relation to human diseases.
- To emphasize how constitutively active TRPV4 mutants affect endochondral ossification.
- To summarize current knowledge on TRPV4's role in disease pathogenesis.
Main Methods:
- Review of existing literature on TRPV4 function, mutations, and associated skeletal disorders.
- Analysis of the molecular mechanisms by which TRPV4 mutations lead to deviated function.
- Focus on the effects of constitutively active TRPV4 mutants on chondrocyte biology and ossification.
Main Results:
- TRPV4 mutations cause severe bone dysplasia characterized by dwarfism, skeletal deformities, and abnormal endochondral ossification.
- Constitutively active TRPV4 mutants impair endochondral ossification by reducing hypertrophic chondrocytes and creating cartilage islands.
- Deviated TRPV4 function contributes to the pathogenesis of various human diseases.
Conclusions:
- TRPV4 plays a significant role in skeletal development and homeostasis.
- Understanding TRPV4's altered function in mutants is key to comprehending the molecular basis of these bone diseases.
- Further research into TRPV4 regulation and function could reveal therapeutic targets for skeletal dysplasias.
Related Concept Videos
Mechanically-gated Ion Channels
Huntington Disease l: Introduction
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Thermosensation
Mutations
Cellular Adaptation IV: Dysplasia and Metaplasia
